PMID: 7031184Oct 1, 1981Paper

Phenylethylmalonamide in essential tremor. A double-blind controlled study

Journal of Neurology, Neurosurgery, and Psychiatry
S CalzettiA Richens

Abstract

A randomised double-blind placebo-controlled trial of phenylethylmalonamide, the major metabolite of primidone was performed in eight patients with essential tremor. Phenylethylmalonamide was given in a daily dose of 400 mg for one week and 800 mg for a second week. The compound had no statistically significant effect on the amplitude of tremor assessed by an accelerometric method, tests of performance, clinical evaluation and patient self assessment. No side effects occurred. Serum levels of phenylethylmalonamide on a daily dose of 400 mg were 11-27 micrograms/ml and on 800 mg daily were 16-48.5 micrograms/ml.

References

Jul 1, 1972·Chemical & Pharmaceutical Bulletin·T KametaniK Takahashi
Jan 17, 1981·British Medical Journal·M D O'BrienP A Toseland

❮ Previous
Next ❯

Citations

Jan 1, 1987·European Journal of Clinical Pharmacology·J M StreeteP Crome
Jun 5, 2002·Current Neurology and Neuroscience Reports·Theresa A ZesiewiczRobert A Hauser
Jul 25, 2013·Current Treatment Options in Neurology·Theresa A ZesiewiczKelly L Sullivan
Oct 1, 1990·British Journal of Clinical Pharmacology·C MartinesE Perucca
Oct 16, 1982·British Medical Journal·W R Gibb
Sep 1, 1985·Journal of Neurology, Neurosurgery, and Psychiatry·L J FindleyS Calzetti
Sep 4, 2009·Paediatric Drugs·Joseph Ferrara, Joseph Jankovic
Mar 10, 2006·The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists·Jack J Chen, Kelly C Lee
Oct 4, 2003·Pharmacotherapy·Jack J Chen, David M Swope
Nov 1, 2012·Thérapie·Danièle Bentué-FerrerOlivier Tribut
Jan 5, 2014·Journal of Central Nervous System Disease·Peter HederaThomas L Davis
Aug 28, 1982·British Medical Journal·R A Harrad, P G Kennedy
May 9, 2003·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Kelly E LyonsRay L Watts
Jan 25, 2020·Current Neuropharmacology·Hortensia Alonso-NavarroFélix J Jiménez-Jiménez
Nov 25, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·P G WasielewskiW C Koller
Aug 28, 1982·British Medical Journal·L J Findley, S Calzetti
Sep 1, 2004·The Neurologist·Kelly L SullivanTheresa A Zesiewicz
Jan 1, 1991·Movement Disorders : Official Journal of the Movement Disorder Society·E SassoS Calzetti

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Neurology, Neurosurgery, and Psychiatry
S CalzettiA Richens
Journal of Neurology, Neurosurgery, and Psychiatry
A Chakrabarti, J M Pearce
© 2021 Meta ULC. All rights reserved